BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND HLF, Q16534, 3131, ENSG00000108924 AND Treatment
5 results:

  • 1. Retrospective analysis of the uptake of active surveillance for low-risk prostate cancer in Zurich, Switzerland.
    Poyet C; Scherer TP; Kunz M; Wanner M; Korol D; Rizzi G; Kaufmann B; Rohrmann S; Hermanns T
    Swiss Med Wkly; 2023 Jul; 153():40103. PubMed ID: 37499067
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
    Cabral-Romero C; Solís-Soto JM; Sánchez-Pérez Y; Pineda-Aguilar N; Meester I; Pérez-Carrillo E; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Hernandez-Delgadillo R; Chellam S; García-Cuéllar CM
    Anticancer Drugs; 2020 Mar; 31(3):251-259. PubMed ID: 31764012
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy.
    Strand SH; Switnicki M; Moller M; Haldrup C; Storebjerg TM; Hedegaard J; Nordentoft I; Hoyer S; Borre M; Pedersen JS; Wild PJ; Park JY; Orntoft TF; Sorensen KD
    Oncotarget; 2017 Jan; 8(4):5774-5788. PubMed ID: 28052017
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.
    Thalgott M; Horn T; Heck MM; Maurer T; Eiber M; Retz M; Autenrieth M; Herkommer K; Krause BJ; Gschwend JE; Treiber U; Kübler HR
    J Hematol Oncol; 2014 Mar; 7():20. PubMed ID: 24598155
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.